Frequency and distribution of Epstein-Barr virus infection and its association with P53 expression in a series of primary nodal non-Hodgkin lymphoma patients from South India

International Journal of Laboratory Hematology

Volumn 32, Issue 1 PART.2, 2010, Pages 56-64

  Sasikala, P S ^a   Nirmala, K ^a   Sundersingh, S ^a   Mahji, U ^a   Rajkumar, T ^a  

^a CANCER INSTITUTE WIA   (India)

Author keywords

Epstein Barr virus; Non hodgkin lymphoma; P53

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 1; PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; FOLLICULAR LYMPHOMA; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INDIA; LARGE CELL LYMPHOMA; LYMPH NODE; LYMPHOBLASTOMA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NONHODGKIN LYMPHOMA; PATHOGENESIS; PERIPHERAL T CELL LYMPHOMA; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; VIRUS INFECTION; VIRUS STRAIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; INDIA; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MUTATION; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77449096723     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2008.01125.x     Document Type: Article

References (43)

1. Bonagura V.R., Katz B.Z., Edwards B.L., Valacer D.J., Nisen P., Gloster E., Mir R. & Lanzkowsky P. (1990) Severe chronic EBV infection associated with specific EBV immunodeficiency and an EBNA1 T-cell lymphoma containing linear, EBV DNA. Clinical Immunology and Immunopathology 57, 32.
2. Cesarman E., Inghirami G., Chadburn A. & Knowles D.M. (1993) High levels of P53 protein expression do not correlate with P53 gene mutations in anaplastic large cell lymphoma. American Journal of Pathology 143, 845-856.
3. Danova M., Giordano M., Mazzini G. & Riccardi A. (1990) Cell cycle-related proteins and flow cytometry. Haematologica 75, 252-264.
4. Deamant F.D., Albújar P.F., Chen Y.Y. & Weiss L.M. (1993) Epstein-Barr virus distribution in nonneoplastic lymph nodes. Modern Pathology 6, 729-732.
5. Dinand V., Dawar R., Arya L.S., Unni R., Mohanty B. & Singh R. (2007) Hodgkin's lymphoma in Indian children: prevalence and significance of Epstein- Barr virus detection in Hodgkin's and Reed-Sternberg cells. European Journal of Cancer 43, 161-168.
6. Enblad G., Sandvej K., Lennette E., Sundström C., Klein G., Glimelius B. & Pallesen G. (1997) Lack of correlation between EBV serology and presence of EBV in the Hodgkin and Reed-Sternbergcells of patients with Hodgkin's disease. International Journal of Cancer 72, 394-397.
7. Epstein M.A. (1964) Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1, 702.
8. Epstein M.A. & Achong B.G. (1973) The EB virus. Annual Review of Microbiology 27, 413-436.
9. Flavell J.R., Baumforth K.R., Wood V.H., Davies G.L., Wei W., Reynolds G.M., Morgan S., Boyce A., Kelly G.L., Young L.S. & Murray P.G. (2008) Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells. Blood 111, 292-301.
10. Hamilton-Dutoit S.J. & Pallesen G. (1992) A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. American Journal of Pathology 140, 1315.
11. Herbst H., Dallenbach F., Hummel M., Niedobitek G., Finn T., Young L.S., Rowe M., Müller-Lantzsch N. & Stein H. (1991) Epstein-Barr virus DNA and latent gene products in Ki-1 (CD30)- positive anaplastic large cell lymphomas. Blood 78, 2666-2673.
12. Hummel M., Anagnostopoulos I., Korbjuhn P. & Stein H. (1995) Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types. Journal of Pathology 175, 263-271.
13. Jaffe E.S., Harris N.L., Stein H. & Vardiman J.W. (eds) (2001) World Health Organization Classification of Tumors: Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues. IARC Press, Lyon, France.
14. Jones J.F., Shurin S., Abramowsky C., Tubbs R.R., Sciotto C.G., Wahl R., Sands J., Gottman D., Katz B.Z. & Sklar J. (1988) T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infection. New England Journal of Medicine 318, 733.
15. Kaye K.M., Izumi K.M. & Kieff E. (1993) Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proceedings of the National Academy of Sciences of the United States of America 90, 9150-9154.
16. Kerbauy F.R., Colleoni G.W., Saad S.T., Regis Silva M.R., Correa Alves A., Aguiar K.C., Albuquerque D.M., Kobarg J., Seixas M.T. & Kerbauy J. (2004) Detection and possible prognostic relevance of p53 gene mutations in diffuse large B-cell lymphoma. An analysis of 51 cases and review of the literature. Leukemia & Lymphoma 45, 2071-2078.
17. Kieff E. & Rickinson A.B. (2001) Epstein- Barr virus and its replication. In: Fields Virology (eds D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin, B. Roizman & S.E. Straus), 4th edn, pp. 2511-2573. Lippincott Williams & Wilkins, Philadelphia, PA.
18. Kim I., Park E.R., Park S.H., Lin Z. & Kim Y.S. (2002) Characteristics of Epstein- Barr virus isolated from the malignant lymphomas in Korea. Journal of Medical Virology 67, 59-66.
19. Kim D., Ko Y., Suh Y., Koo H., Huh J. & Lee W. (2005) Characteristics of Epstein-Barr virus associated childhood non-Hodgkin's lymphoma in the Republic of Korea. Virchows Archiv 447, 593-596.
20. Klumb C.E., Hassan R., Zalcberg I.R., Resende L.M., Carriço M.K. & Maia R.C. (2004) p53 protein expression does not correlate with EBV status in childhood B non-Hodgkin lymphomas. Pediatric Blood & Cancer 43, 115-119.
21. Menke D.M., Griesser H., Moder K.G., Tefferi A., Luthra H.S., Cohen M.D., Colon-Otero G. & Lloyd R.V. (2000) Lymphomas in patients with connective tissue disease. Comparison of p53 protein expression and latent EBV infection in patients immunosuppressed and not immunosuppressed with methotrexate. American Journal of Clinical Pathology 113, 212-218.
22. Mitarnun W., Pradutkanchana J. & Ishida T. (2004) Epstein-Barr virus-associated nodal malignant lymphoma in Thailand. Asian Pacific Journal of Cancer Prevention 5, 268-272.
23. Naresh K.N., Srinivas V. & Soman C.S. (2000) Distribution of various subtypes of non-Hodgkin's lymphoma in India: a study of 2773 lymphomas using R.E.A.L. and WHO Classifications. Annal Oncology 11(Suppl. 1), 63-67.
24. Neri A., Barriga F., Inghirami G., Knowles D.M., Neequaye J., Magrath I.T. & Dalla- Favera R. (1991) Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency-associated lymphoma. Blood 77, 1092.
25. Niedobitek G. & Young L.S. (1994) Epstein-Barr virus persistence and virus-associated tumors. Lancet 343, 333-335.
26. Noorali S., Pervez S., Yaqoob N., Moatter T., Nasir M.I., Haroon S., Hodges E. & Smith J.L. (2004) Prevalence and characterization of anaplastic large cell lymphoma and its association with Epstein-Barr virus in Pakistani patients. Pathology, Research and Practice 200, 669-679.
27. Paydas S., Ergin M., Erdogan S. & Seydaoglu G. (2008) Prognostic significance of EBV-LMP1 and VEGF-A expressions in non-Hodgkin's lymphomas. Leukemia Research 32, 1424-1430.
28. Peh S.C. (2001) Host ethnicity influences non-Hodgkin's lymphoma subtype frequency and Epstein-Barr virus association rate: the experience of a multiethnic patient population in Malaysia. Histopathology 38, 458-465.
29. Raab-Traub N. (2002) Epstein-Barr virus in the pathogenesis of NPC. Seminars in Cancer Biology 12, 431-441.
30. Rickinson A.B. & Kieff E. (1996) Epstein- Barr virus. In: Fields Virology (eds B.N. Fields, D.M. Knipe & P.M. Howley), pp. 2397-2446. Lippincott-Raven, Philadelphia, PA.
31. Rickinson A.B. & Kieff E. (2001) Epstein- Barr virus. In: Fields Virology (eds D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin, B. Roizman & S.E. Straus), 4th edn, pp. 2575-2627. Lippincott Williams & Wilkins, Philadelphia, PA.
32. Su I.J., Hsieh H.C., Lin K.H., Uen W.C., Kao C.L., Chen C.J., Cheng A.L., Kadin M.E. & Chen J.Y. (1991) Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood 77, 799.
33. Taylor G. (2007) Molecular aspects of HTLV-I infection and adult T-cell leukaemia/ lymphoma. Journal of Clinical Pathology 60, 1392-1396.
34. Venkitaraman A.R., Lenoir G.M. & John T.J. (1985) The seroepidemiology of infection due to Epstein-Barr virus in southern India. Journal of Medical Virology 15, 11-16.
35. Villuendas R., Pezzella F., Gatter K., Algara P., Sánchez-Beato M., Martínez P., Martínez J.C., Muñoz K., García P., Sánchez L., Kocialkowsky S., Campo E., Orradre J.L. & Piris M.A. (1997) p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations. Journal of Pathology 181, 51-61.
36. Weiss R.A. (1999) Viruses, cancer and AIDS. FEMS Immunology and Medical Microbiology 26, 227-232.
37. Weiss L.M., Jaffe E.S., Liu X.F., Chen Y.Y., Shibata D. & Medeiros L.J. (1992) Detection and localization of Epstein- Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood 79, 1789-1795.
38. Wilson J.B., Bell J.L. & Levine A.J. (1996) Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO Journal 15, 3117-3126.
39. Xerri L., Parc P., Bouabdallah R., Camerlo J. & Hassoun J. (1995) PCR-mismatch analysis of p53 gene mutation in Hodgkin's disease. Journal of Pathology 175, 189-194.
40. Yates J.L., Camiolo S.M. & Bashaw J.M. (2000) The minimal replicator of Epstein-Barr virus oriP. Journal of Virology 74, 4512-4522.
41. Young K.H., Weisenburger D.D., Dave B.J., Smith L., Sanger W., Iqbal J., Campo E., Delabie J., Gascoyne R.D., Ott G., Rimsza L., Müller-Hermelink H.K., Jaffe E.S., Rosenwald A., Staudt L.M., Chan W.C. & Greiner T.C. (2007) Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor- 2, predict for poor survival in diffuse large B-cell lymphoma. Blood 110, 4396-4405.
42. Zhou X.G., Hamilton-Dutoit S.J., Yan Q.H. & Pallesen G. (1994) High frequency of Epstein-Barr virus in Chinese peripheral T-cell lymphoma. Histopathology 24, 115.
43. Zur Hausen H., Schutte-Holthausen H., Klein G., Henle W., Henle G., Clifford P. & Santesson L. (1970) EBV DNA in biopsies of Burkitt tumors and anaplastic Carcinomas of the nasopharrynx. Nature 228, 1056.